Raffles Medical posts 63.8% drop in H2 profit to S$30.3 million; looks to China, Japan growth
RAFFLES Medical Group : BSL 0% posted a 63.8 per cent drop in net profit to S$30.3 million for the second half ended Dec 31, 2023, from S$83.7 million in the previous corresponding period.
The group attributed the weaker performance to the discontinuation of Covid-19-related activities in FY2023, it said on Monday (Feb 26).
The results translate to earnings per share (EPS) of 1.63 Singapore cents against EPS of 4.51 cents previously.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
iFast prices S$100 million notes due 2029 at 4.328%
Choose bonds over stocks as central banks cut rates, says UBS Wealth Management
Google’s latest data centre raises its investment in Singapore to S$6.7 billion
China’s Great Wall Motor closes European HQ and lays off workers
NYSE resolves glitch that led to volatility pause for dozens of stocks
US: Wall Street opens higher on chip and megacaps boost